argenx reports positive phase 3 data for autoimmune myositis drug
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Russia pounds power facilities around Kyiv, damages major bridge
Three days before Russia and Ukraine are due to take part in U.S.-brokered talks, explosions rocked Kyiv as Moscow unleashed waves of ballistic missiles.
Russia pounds power facilities around Kyiv, damages major bridge
Three days before Russia and Ukraine are due to take part in U.S.-brokered talks, explosions rocked Kyiv as Moscow unleashed waves of ballistic missiles.
AMD Stock Popped After Earnings, Then Gave It All Back. Is It a Buy Now?
AMD's results were good, but the overall picture of the stock isn't as great.
- AMD's stock surged 8% after-hours on Nov 3 following strong earnings
- Stock only rose 1% next day, trailing S&P 500 gains
- AMD's data center revenue grew 97% YoY to $8.5B, but overall revenue up 45%
Here's How These 6 Big Bank Stocks Make Their Money
Key PointsJPMorgan Chase, Bank of America, Citigroup, and Morgan Stanley are leaning on fee businesses, which are growing at double-digit rates.
A Netflix Show Returns With A Second 100% Rotten Tomatoes Scored Season
Not many Netflix series manage to secure two 100% Rotten Tomatoes scored seasons in a row, but this one has.